Characterized SL genes | Role in SL pathway | A. thaliana reference | P. aegyptiaca | S. hermonthica | T. versicolor |
|
| Accession (Amino acid length) | Extent of coding sequence identified (Amino acid length, identity to A. thaliana) | ||
D27Os* | Biosynthesis of SL precursor | AT1G03055 (264) | Full (251, 41.9%) | Partial (73, 53.6%) | Partial (232, 41.0%) |
CCD7/MAX3At, RMS5Ps, D17Os, DAD3Ph | Biosynthesis of SL precursor | AT2G44990 (629) | Full (652, 55.3%) | Partial (533, 45.2%) | Fragments |
CCD8/MAX4At, RMS1Ps, D10Os, DAD1Ph | Biosynthesis of carlactone | AT4G32810 (570) | Full (563, 60.3%) | Partial (214, 67.8%) | Partial (279, 65.7%) |
MAX1At | Conversion to bioactive SL | AT2G26170 (522) | Full (526, 68.5%) | Full (523, 65.8%) | Full (478, 65.5%) |
MAX2At, RMS4Ps, D3Os | Mediates signaling (Both SL and karrikin signals) | AT2G42620 (693) | Full (709, 55.9%) | Full (703, 56.6%) | Partial (296, 50.3%) |
D14Os, DAD2Ph | Signal perception (SL binding) | AT3G03990 (267) | Full (266, 77.2%) | Partial (180, 76.8%) | Full (273, 62.1%) |
KAI2At | Homolog of D14. Related to karrikin signaling. | AT4G37470 (270) | Full (270, 75.2%) | Full (271, 75.6%) | Full (272, 73.9%) |
PDR12At, PDR1Ph | SL transport | AT1G15520 (1423) | Full (1428, 69.0%) | Full (1440, 68.3%) | Full (1491. 67.2%) |